HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637HAB5. A total of 17 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SSI INVESTMENT MANAGEMENT LLC | 5,511,000 | $10,091,000 | 0.73% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 11,000,000 | $20,287,000 | 0.52% |
| WOLVERINE ASSET MANAGEMENT LLC | 27,653,000 | $50,747,000 | 0.43% |
| MIZUHO SECURITIES USA LLC | 1,300,000 | $2,387,000 | 0.23% |
| Calamos Advisors LLC | 10,000,000 | $18,389,000 | 0.10% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,000,000 | $3,676,000 | 0.09% |
| LINDEN ADVISORS LP | 5,000,000 | $9,183,000 | 0.07% |
| BNP PARIBAS FINANCIAL MARKETS | 3,436,000 | $6,304,922,000 | 0.01% |
| Kohlberg Kravis Roberts & Co. L.P. | 1,000,000 | $1,833,000 | 0.01% |
| Invesco Ltd. | 5,320,000 | $9,742,000 | 0.00% |